Show simple item record

dc.contributor.authorvan Nieuwkoop, Cees
dc.contributor.authorvan der Starre, Willize E
dc.contributor.authorStalenhoef, Janneke E
dc.contributor.authorvan Aartrijk, Anna M
dc.contributor.authorvan der Reijden, Tanny J K
dc.contributor.authorVollaard, Albert M
dc.contributor.authorDelfos, Nathalie M
dc.contributor.authorvan 't Wout, Jan W
dc.contributor.authorBlom, Jeanet W
dc.contributor.authorSpelt, Ida C
dc.contributor.authorLeyten, Eliane M S
dc.contributor.authorKoster, Ted
dc.contributor.authorAblij, Hans C
dc.contributor.authorvan der Beek, Martha T
dc.contributor.authorKnol, Mirjam J
dc.contributor.authorvan Dissel, Jaap T
dc.date.accessioned2018-01-24T11:13:59Z
dc.date.available2018-01-24T11:13:59Z
dc.date.issued2017-04-03
dc.identifier.citationTreatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women. 2017, 15 (1):70 BMC Meden
dc.identifier.issn1741-7015
dc.identifier.pmid28366170
dc.identifier.doi10.1186/s12916-017-0835-3
dc.identifier.urihttp://hdl.handle.net/10029/621233
dc.description.abstractIn adults with febrile urinary tract infection (fUTI), data on optimal treatment duration in patients other than non-pregnant women without comorbidities are lacking.
dc.language.isoenen
dc.rightsArchived with thanks to BMC medicineen
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshCiprofloxacin
dc.subject.meshDouble-Blind Method
dc.subject.meshDrug Administration Schedule
dc.subject.meshFemale
dc.subject.meshFever
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNetherlands
dc.subject.meshPlacebos
dc.subject.meshTime Factors
dc.subject.meshUrinary Tract Infections
dc.titleTreatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.en
dc.typeArticleen
dc.identifier.journalBMC Med 2017; 15(1):70en
html.description.abstractIn adults with febrile urinary tract infection (fUTI), data on optimal treatment duration in patients other than non-pregnant women without comorbidities are lacking.


This item appears in the following Collection(s)

Show simple item record